Should Health Systems Share Genetic Findings With At-Risk Relatives When the Proband Is Deceased? Interviews With Individuals Diagnosed With Lynch Syndrome
Abstract
Purpose:Genetic information has health implications for patients and their biological relatives. Death of a patient before sharing a genetic diagnosis with at-risk relatives is a missed opportunity to provide important information that could guide interventions to minimize cancer-related morbidity and mortality in relatives.
Methods:We performed semi-structured interviews with individuals diagnosed with Lynch syndrome at 1 of 4 health systems to explore their perspectives on whether health systems should share genetic risk information with relatives following a patient's death. An inductive, open-coding approach was used to analyze audio-recorded content, with software-generated code reports undergoing iterative comparative analysis by a qualitative research team to identify broad themes and representative participant quotes.
Results:Among 23 participating interviewees, 19 supported health systems informing relatives about their Lynch syndrome risk while the remaining 4 were conflicted about patient privacy. Most (n=22) wanted their Lynch syndrome diagnosis shared with relatives if they were unable to share and to be informed of their own risk if a diagnosed relative was unable to share. The most common issues noted regarding information-sharing with relatives included patient privacy and privacy laws (n=8), potential anxiety (n=5), and lack of contact information for relatives (n=3). Interviewee perspectives on how health systems could communicate genetic findings generated a consensus: When - a few months after but within a year of the patient's death; How - explanatory letter and follow-up phone call; and Who - a knowledgeable professional.
Conclusions: Interviews demonstrated strong and consistent perspectives from individuals diagnosed with Lynch syndrome that health systems have a role and responsibility to inform relatives of genetic findings following a patient's death.
Research topics
Related publications
View all publications- Suchyta SP, Sipkovsky S, Halgren RG, Kruska R, Elftman M, Weber-Nielsen M, Vandehaar MJ, Xiao L, Tempelman RJ, Coussens PM.Physiol Genomics. 16(1):8-18.2003 Dec 16
- Chae L, Sudat S, Dudoit S, Zhu T, Luan S.Mol Plant. 2(1):84-107. doi: 10.1093/mp/ssn083.2009 Jan 01
- Morgan TM, Xiao L, Lyons P, Bethany Kassebaum B, Krumholz HM, Spertus JA.BMC Medical Genetics 9:66 doi:10.1186/1471-2350-9-662008 Jul 12
- Sporer KR, Xiao L, Tempelman RJ, Burton JL, Earley B, Crowe MA.Vet Immunol Immunopathol. 121(3-4):300-20. Epub 2007 Oct 23.2008 Feb 15
- Kraft SA, Cho MK, Gillespie K, Halley M, Varsava N, Ormond KE, Luft HS, Wilfond BS, Soo-Jin Lee S.Am J Bioeth. 18(4):3-20. doi: 10.1080/15265161.2018.1431322.2018 Apr 01




